淚道設備市場規模、佔有率和成長分析（按產品、應用、最終用途和地區）- 產業預測 2025-2032

2023 年淚道設備市場規模價值為 1.6519 億美元，預計將從 2024 年的 1.7147 億美元成長到 2032 年的 2.3108 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 3.8%。

隨著各個年齡層的人對眼部疾病的認知和診斷不斷提高，淚道設備市場正在經歷強勁成長。隨著眼部疾病的增多，對穿刺塞、淚點支架、灌溉系統等先進設備的需求也日益增加。技術進步和手術技術的改進正在改善患者的治療效果，進一步推動市場的擴張。人口老化，加上與老齡化相關的眼科疾病的快速增加，推動了這一成長軌跡。製造商和醫療保健提供者注重護理品質和舒適度，正在創新解決方案以滿足淚液疾病患者的需求。監管因素和報銷政策也對市場動態重大影響。總體而言，市場為專注於以患者為中心的解決方案和改善治療結果的眼科設備製造商提供了有利可圖的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 監管格局
• 專利分析

淚道設備市場規模（依產品及複合年成長率） (2025-2032)

• 市場概況
• 插管套件
• 支架和管
• 套管和刮刀
• 擴充器

淚道設備市場規模（依應用分類）及複合年成長率（2025-2032）

• 市場概況
• 青光眼
• 眼睛乾澀
• 淚腺發炎
• 溢淚
• 其他

淚道設備市場規模（依最終用途和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 診斷中心
• 門診護理中心 (ACC)

淚道設備市場規模（依地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• FCI Ophthalmics（France）
• Kaneka Corporation（Japan）
• Cook Group（USA）
• BVI（UK）
• Rumex International（USA）
• Bess Medical Technology GmbH（Germany）
• Bausch and Lomb Incorporated（USA）
• Braun Melsungen AG（Germany）
• OASIS Medical, Inc.（USA）
• Beaver-Visitec International（USA）
• FC Optics Ltd.（Israel）
• OptiMedica Corporation（USA）
• Diamatrix Ltd.（UK）
• FCI SAS（France）
• Novartis AG（Switzerland）
• Eye Kon Medical, Inc.（USA）

結論和建議

Lacrimal Devices Market size was valued at USD 165.19 million in 2023 and is poised to grow from USD 171.47 million in 2024 to USD 231.08 million by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across all age demographics. With a rise in eye-related disorders, there's an increased demand for advanced devices like punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and improved surgical techniques have enhanced patient outcomes, propelling market expansion further. The aging population, coupled with a surge in age-related ocular issues, sustains this growth trajectory. Manufacturers and healthcare providers are innovating solutions tailored to address the needs of patients with lacrimal disorders, emphasizing quality of care and comfort. Regulatory factors and reimbursement policies also significantly impact market dynamics. Overall, this market presents lucrative opportunities for ophthalmic device companies focused on patient-centric solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily driven by the rising prevalence of eye disorders worldwide. Contributing factors include an aging population, evolving lifestyles, and increased screen time, all of which have led to a surge in conditions such as dry eye syndrome and other disorders affecting the lacrimal system. As a result, there is a heightened demand for lacrimal devices designed to facilitate the diagnosis and treatment of these issues, significantly stimulating market expansion. Furthermore, greater awareness and advances in technology are likely to enhance the adoption of these devices, further fueling growth in the lacrimal devices sector.

Restraints in the Lacrimal Devices Market

A significant constraint in the lacrimal devices market is the tough regulatory environment, along with the potential for delays in securing approvals for new products or modifications. In regions like North America and Europe, regulatory agencies impose rigorous standards for medical devices, which can extend the time required for market entry. These challenges not only hinder the pace of innovation but also affect market expansion, presenting difficulties for both established companies and new market entrants. Consequently, navigating this complicated approval process can stunt overall growth within the lacrimal devices sector, limiting opportunities for advancement and development.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is witnessing a pronounced shift towards minimally invasive procedures, reflecting a broader trend in healthcare that prioritizes patient comfort and quicker recovery. Both patients and healthcare professionals are increasingly favoring techniques that minimize surgical intervention for lacrimal system disorders, resulting in fewer postoperative complications. This growing demand for less invasive solutions has spurred innovation in the development of advanced lacrimal devices, including microendoscopes, specialized catheters, and other state-of-the-art tools. As these technologies evolve, they are set to enhance treatment efficacy and redefine patient care standards, positioning minimally invasive options as the preferred choice in the lacrimal devices market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Global Lacrimal Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• FCI Ophthalmics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations